MedTrace Logo

Identification and Removal of the Non Palpable Etonogestrel Contraceptive Implant

NCT02986204 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-04-30

No results posted yet for this study

Summary

This study will investigate in-office ultrasound localization vs localization in radiology for identification and removal of non palpable etonogestrel (ENG) contraceptive implants and aims to help establish best practices in this domain. Investigators will also create an ultrasound image gallery of palpable and non palpable as well as instructional video for non palpable ENG implant removal.

Conditions

  • Women With an ENG Contraceptive Implant

Interventions

PROCEDURE

removal of ENG implant

the researcher(s) will ask you to: Visit 1 - SCREENING VISIT * questions about your medical/contraception history * Review medical record * physical examination * urine sample for pregnancy test Visit 2a - Radiology * Have an ultrasound of your arm * The radiologist will mark your arm at the location of the implant. Visit 2b * ultrasound of your arm to locate the implant. This is done by feeling the area. * Have your ENG implant removed through a numbed small cut. The researcher will apply a pressure bandage to the site(s). This will reduce bleeding/decrease swelling. * Have the removal procedure video recorded. Visit 3 - FOLLOW UP VISIT approximately 2 weeks after Visit 2: * Provide a urine sample for pregnancy test * Have the implant removal site examined

PROCEDURE

continuation of ING implant

the researcher(s) will ask you to: * To answer questions about your medical and contraception history * Review your medical record * Have a physical examination by the researcher * Provide a urine sample for pregnancy test * Have an ultrasound of your arm

Sponsors & Collaborators

Principal Investigators

  • UCLA Dept. OB/GYN Div. of Family Planning · University of California, Los Angeles

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02986204 on ClinicalTrials.gov